The Latest Cardiac and Vascular News
MINNEAPOLIS, Oct. 2, 2019 /PRNewswire/ — Preventice Solutions announced today it received a tender from the UK Biobank to provide the BodyGuardian® MINI remote cardiac monitor for a cardiovascular monitoring study involving up to 30,000 participants. The study is designed to capture data on asymptomatic heart rhythm disturbances (arrhythmia), including atrial fibrillation (AF), […]
SAN CARLOS, Calif., Oct. 02, 2019 (GLOBE NEWSWIRE) — BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the appointment of experienced CEOs Jim Allen and Andrew Blank to its Board of Directors, effective October 1, 2019. Mr. Allen is Chief Executive Officer and […]
LAKE FOREST, Ill., Oct. 1, 2019 /PRNewswire/ — Today, the American Heart Association (AHA), the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke, announced that it has appointed Ranndy Kellogg, president and CEO of Omron Healthcare, Inc., to its Metro Chicago board of directors. Omron Healthcare is the […]
Caption Guidance, the company’s transformational ultrasound software, successfully meets primary endpoints in pivotal clinical study Food and Drug Administration (FDA) grants Breakthrough Device Designation to Caption Guidance SAN FRANCISCO, Oct. 1, 2019 /PRNewswire/ — Bay Labs, a growing medical technology company applying deep learning technology to emulate the expertise of highly-trained medical experts, […]
SAN CARLOS, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) — BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the U.S. commercial availability of its AVANCE™ Bi-Directional Steerable Introducer Sheath for introducing various cardiovascular catheters into the heart, including via the left side of the heart through […]
LOS ANGELES–(BUSINESS WIRE)–Sensydia Corporation, an innovator in rapid, non-invasive measurement of critical cardiac function, announced that industry leader Anthony Arnold has been appointed as chief executive officer and president and joins the Board of Directors. Arnold is a pioneer in bioelectronic medicine and surgical navigation and brings more than 20 years of […]
Leaders in business intelligence and the cardiovascular space use knowledge exchange and thought leadership in working towards better care and lower costs LUMEDX, a market leader in cardiovascular information systems (CVIS) and cutting-edge business intelligence solutions for more than 25 years, is excited to announce its industry partnership with MedAxiom, […]
After completing a 60-day pre-clinical study, Professor Stephen Wildhirt, MD, PhD, CEO at AdjuCor, is excited to report on its success. Apart from other achievements, the study confirmed the chronic physiologic acceptance of their non-blood-contacting biventricular cardiac support device by the body. AdjuCor has previously completed a successful 30-day in vivo study. […]
– New data presented at TCT 2019 on Abbott’s TriClip device from the TRILUMINATE Feasibility Study met both the primary safety and performance endpoints – Abbott’s TriClip tricuspid valve repair system design is based on the company’s market-leading MitraClip™ technology SAN FRANCISCO, Sept. 28, 2019 /PRNewswire/ — Abbott (NYSE: ABT) today announced new […]
FRANKLIN LAKES, N.J., Sept. 28, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the publication of a company-initiated, independent analysis of the LUTONIX® 035 Drug Coated Balloon (DCB) femoropopliteal clinical program in the Journal of the American College of Cardiology (JACC): Cardiovascular Interventions. These data were simultaneously presented […]
